Literature DB >> 18333256

Liver resection for hepatic metastases from adrenocortical carcinoma.

Isidoro Di Carlo1, Adriana Toro, Francesca Sparatore, Stefano Cordio.   

Abstract

Liver metastases from adrenocortical carcinoma are very rare and no clear indications for surgery exist. The aim of the present work was to define surgical indications for these neoplasms. All the patients submitted to hepatic resection for liver metastases from adrenal carcinoma reported in the literature (PubMed source) from 1978 to 2005 were considered for the present study. Forty-eight patients were found in the period of study, but it was only possible to obtain certain data for nine patients (18.7%). The data investigated suggest that metachronous metastases, developed after a minimum of 1 year from the primary tumor, and completely removable, may represent an indication for surgery - although this still needs to be proved.

Entities:  

Year:  2006        PMID: 18333256      PMCID: PMC2131421          DOI: 10.1080/13651820500471848

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  16 in total

1.  Liver anatomy: portal (and suprahepatic) or biliary segmentation.

Authors:  C Couinaud
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  Hepatic resection of noncolorectal nonneuroendocrine metastases.

Authors:  A W Hemming; T D Sielaff; S Gallinger; M S Cattral; B R Taylor; P D Greig; B Langer
Journal:  Liver Transpl       Date:  2000-01       Impact factor: 5.799

3.  Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients.

Authors:  L E Harrison; M F Brennan; E Newman; J G Fortner; A Picardo; L H Blumgart; Y Fong
Journal:  Surgery       Date:  1997-06       Impact factor: 3.982

4.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Two-stage subtotal hepatectomy for metastatic adrenal adenocarcinoma, a case report.

Authors:  R N Williams; S A White; D M Lloyd
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

6.  Adrenocortical carcinoma: experience in 45 patients.

Authors:  L Barzon; F Fallo; N Sonino; O Daniele; M Boscaro
Journal:  Oncology       Date:  1997 Nov-Dec       Impact factor: 2.935

7.  Primary adrenocortical carcinoma and delayed liver metastasis: is the surgery alone the right treatment? Case report.

Authors:  Isidoro Di Carlo; Francesco Barbagallo; Adriana Toro; Maria Sofia; Stefano Cordio; Giuseppe Grasso
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

8.  Survival after liver resection for secondary tumors.

Authors:  J H Foster
Journal:  Am J Surg       Date:  1978-03       Impact factor: 2.565

9.  Personal experience with 411 hepatic resections.

Authors:  S Iwatsuki; T E Starzl
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

10.  Results of surgical resection of liver metastases from non-colorectal primaries.

Authors:  T Berney; G Mentha; A D Roth; P Morel
Journal:  Br J Surg       Date:  1998-10       Impact factor: 6.939

View more
  2 in total

1.  Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.

Authors:  Reed I Ayabe; Raja R Narayan; Samantha M Ruff; Michael M Wach; Winifred Lo; Pieter M H Nierop; Seth M Steinberg; R Taylor Ripley; Jeremy L Davis; Bas G Koerkamp; Michael I D'Angelica; T Peter Kingham; William R Jarnagin; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2019-08-22       Impact factor: 3.647

2.  Operative management for recurrent and metastatic adrenocortical carcinoma.

Authors:  Nicole M Datrice; Russell C Langan; R Taylor Ripley; Clinton D Kemp; Seth M Steinberg; Bradford J Wood; Steven K Libutti; Tito Fojo; David S Schrump; Itzhak Avital
Journal:  J Surg Oncol       Date:  2011-12-20       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.